American cancer death rate dropped 27% over last quarter-century

Deaths from cancer in the United States declined 27 percent from a peak in 1991, according to the American Cancer Society. The steady drop over the 25-year period ending 2016 translates to more than 2.6 million avoided deaths and an annual reduction of about 1.5 percent.

One of the major causes of the drop is a decline in smoking––which causes 25 percent of all cancer deaths––over the last quarter-century. Early detection and advances in treatment are also playing a role, but the benefits are not equal across all populations. Variances exist based on gender, demographics, geographic location, socioeconomic conditions, age and more, according to the American Cancer Society’s annual report.

“Although the racial gap in cancer mortality is slowly narrowing, socioeconomic inequalities are widening, with residents of the poorest counties experiencing an increasingly disproportionate burden of the most preventable cancers,” the report reads. “A broader application of existing cancer control knowledge with an emphasis on disadvantaged groups would undoubtedly accelerate progress against cancer.”

Cancer rates

Overall, the lifetime probability of being diagnosed with cancer is 39 percent for men and 38 percent for women. In 2019, about 1.8 million new cancer cases and 607,000 deaths are expected to occur in the nation. Cancer was the second leading cause of death after heart disease in 2016, causing 22 percent of all deaths.

From 2006 to 2015, new cancer diagnoses for men fell about 2 percent per year but remained around the same for women. Cancer death rates for men from 2007 to 2016 dropped 1.8 percent per year and 1.4 percent for women.

Among men, the most common cancers are prostate, lung and colorectal, accounting for 42 percent of all cases and nearly one in five new cases. Among women, breast, lung and colorectal are the most common cancers, with breast cancer alone account for 30 percent of new cases.

Across demographics, the rates of both new cancer cases and deaths vary among racial and ethnic groups, according to the report. Rates are generally highest among African Americans and lowest among Asian Americans, with the 2016 cancer death high 14 percent higher in blacks than whites. By comparison, that gap reached a peak of 33 percent in 1993. A decline in smoking among black teens has contributed to this drop.

Socioeconomic status also factors into cancer rates, with people living in the poorest U.S. counties more likely to smoke and be obese. From 2012 to 2016, death rates were two times higher for cervical cancer and 40 percent higher for male lung and liver cancers in the poorest counties compared to the richest counties. People in poverty are also less likely to get the best treatment and routine cancer screenings, with a later stage at diagnosis.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.